CMAC
Home
Journal Archive
Subscription
About
About
Author Guidelines
Editorial Board
Peer Review
Publishing Ethics
English
Русский
CMAC 2023; 25(1)
Type
Review
Clinical Case
Original Article
Sections
Antimicrobial Resistance
Antimicrobials
Diseases and Pathogens
Personal Experience
Current approaches and prospects for the development of laboratory diagnosis of measles
Measles virus causes an acute infectious disease with high contagiousness. It is possible to limit the spread of measles virus only …
Nosova A.O.
,
Bogoslovskaya E.V.
,
Shipulin G.A.
Clinical Microbiology and Antimicrobial Chemotherapy. 2023; 25(1):4-12
10.36488/cmac.2023.1.4-12
PDF
Cite
Fusobacterium nucleatum
: from a classic periodontal pathogen to a complete participant of carcinogenesis
Fusobacterium nucleatum
is a component of the oral microflora, and in clinical practice it is associated primarily with periodontal …
Kaiumov K.A.
,
Lyamin A.V.
,
Zhestkov A.V.
,
Bazhutova I.V.
Clinical Microbiology and Antimicrobial Chemotherapy. 2023; 25(1):13-18
10.36488/cmac.2023.1.13-18
PDF
Cite
Aztreonam: clinical and pharmacological characteristics at the present stage
One of the urgent problems of modern health care is the growing resistance of microorganisms to antibiotics, including carbapenems, …
Popov D.A.
,
Zubareva N.A.
,
Parshakov A.A.
Clinical Microbiology and Antimicrobial Chemotherapy. 2023; 25(1):19-25
10.36488/cmac.2023.1.19-25
PDF
Cite
Report of the Russian database on adverse drug reactions for COVID-19-related drugs with a focus on favipiravir
Objective. The purpose of this study is to systematize and comprehensively evaluate safety data on the drug favipiravir using the …
Mishinova S.A.
,
Syraeva G.I.
,
Kolbin A.S.
,
Polushin Yu.S.
,
Verbiсkaya E.V.
Clinical Microbiology and Antimicrobial Chemotherapy. 2023; 25(1):26-33
10.36488/cmac.2023.1.26-33
PDF
Cite
Adverse drug reactions of macrolide therapy: analysis of spontaneous reports according to the Pharmacovigilance system
Objective. To perform pharmacoepidemiological analysis of spontaneous reports of adverse drug reactions (ADRs) occurred during …
Skryabina A.A.
,
Nikiforov V.V.
,
Shakhmardanov M.Z.
,
Zastrozhin M.S.
,
Skryabin V.Yu.
,
Sychev D.A.
Clinical Microbiology and Antimicrobial Chemotherapy. 2023; 25(1):34-40
10.36488/cmac.2023.1.34-40
PDF
Cite
The known-unknown: third- and fourth-generation cephalosporins combined with sulbactam
Despite the presence of more than 100 different antibacterials in the therapeutic arsenal, beta-lactam antibiotics, in general, and the …
Stetsiouk O.U.
,
Kovalenko T.N.
,
Andreeva I.V.
,
Belkova Yu.A.
Clinical Microbiology and Antimicrobial Chemotherapy. 2023; 25(1):41-55
10.36488/cmac.2023.1.41-55
PDF
Cite
Prospects for the use of statins in antiviral therapy
Inhibitors of hydroxymethylglutaryl-CoA reductase, in addition to suppressing cholesterol synthesis, have an antiviral effect. Clinical …
Mustafin R.N.
Clinical Microbiology and Antimicrobial Chemotherapy. 2023; 25(1):56-67
10.36488/cmac.2023.1.56-67
PDF
Cite
AMRexpert – online platform for interpretation, verification and validation of antimicrobial susceptibility testing
Objective. To review the key principles and functionality of AMRexpert online platform. Materials and Methods. The information part of …
Vinogradova A.G.
,
Kuzmenkov A.Yu.
,
Trushin I.V.
,
Edelstein M.V.
,
Sukhorukova M.V.
,
Starostenkov A.A.
Clinical Microbiology and Antimicrobial Chemotherapy. 2023; 25(1):68-76
10.36488/cmac.2023.1.68-76
PDF
Cite
Anti-staphylococcal activity and cytocompatibility of lysostaphin
Objective. To study the antibacterial activity of lysostaphin against staphylococci various species, as well as its effect on the …
Gordina E.M.
,
Bozhkova S.A.
,
Labutin D.V.
,
Goncharuk D.A.
,
Tkach E.N.
Clinical Microbiology and Antimicrobial Chemotherapy. 2023; 25(1):77-82
10.36488/cmac.2023.1.77-82
PDF
Cite
Patterns of antimicrobial dispensing in community pharmacies in Russia during the COVID-19 pandemic
Objective. To evaluate the existing patterns of antimicrobials dispensing in community pharmacies during the COVID-19 pandemic. …
Kurkova A.A.
,
Rachina S.A.
,
Kozlov R.S.
,
Portnyagina U.S.
,
Palyutin Sh.Kh.
,
Reshetko O.V.
,
Zhuravleva M.V.
,
Karpova O.Yu.
,
Myagkova O.G.
,
Kuznetsova E.V.
,
Kameneva T.R.
Clinical Microbiology and Antimicrobial Chemotherapy. 2023; 25(1):84-92
10.36488/cmac.2023.1.84-92
PDF
Cite
COVID-19 risk factors for mortality in hospitalized patients: results of a retrospective study
Objective. To identify risk factors for fatal outcome and COVID-19-associated liver damage in hospitalized adult patients with …
Safonova K.A.
,
Dekhnich N.N.
,
Elistratov N.D.
,
Rzhevtseva E.D.
,
Filina P.G.
,
Kuzmenkov A.Yu.
,
Trushin I.V.
,
Punin A.A.
Clinical Microbiology and Antimicrobial Chemotherapy. 2023; 25(1):93-99
10.36488/cmac.2023.1.93-99
PDF
Cite
Infective endocarditis caused by
Klebsiella pneumoniae
in a patient with non ST elevation myocardial infarction
A rare clinical case of native aortic valve infective endocarditis (IE) caused by
Klebsiella pneumoniae
in a 56-year old man without …
Zhilinskiy M.Yu.
,
Mukhina N.V.
,
Komarova I.S.
,
Rachina S.A.
,
Cherkasova N.A.
,
Borisov A.B.
,
Fedina L.V.
,
Nasrulloeva S.M.
Clinical Microbiology and Antimicrobial Chemotherapy. 2023; 25(1):100-105
10.36488/cmac.2023.1.100-105
PDF
Cite
Pulmonary aspergilloma after previous COVID-19: a case report and a literature review
Pulmonary aspergillosis has always been considered as a disease that occurs in patients with certain risk factors for its development. …
Ovsyannikov N.V.
,
Bilevich O.A.
,
Berezhnoy V.G.
,
Romanovskaya E.V.
,
Zyatkov I.N.
,
Minkovich O.P.
,
Eshtokin D.I.
Clinical Microbiology and Antimicrobial Chemotherapy. 2023; 25(1):106-112
10.36488/cmac.2023.1.106-112
PDF
Cite
Cite
×
